FDA Approved: * March 4, 2019 Pharm Company: *AMNEAL PHARMS CO Category:Cancer
Fulvestrant, sold under the brand name Faslodex among others, is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with palbociclib in women with disease progression after endocrine therapy.[2] It is given by injection into a muscle.[3]
Fulvestrant is a selective estrogen receptor degrader (SERD) and was f...
[wikipedia]
* May have multiple approval dates, manufacturers, or labelers. 2 Discussions
1 REPLY